Cooking up better diabetes control: can virtual classes teach teens healthier habits?
NCT ID NCT07780487
The trial has finished. Results may not be published yet.
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This trial tests whether virtual cooking classes, held twice a month for three months, can help teenagers with type 1 diabetes improve their blood sugar control and learn healthier eating habits. Participants, aged 12 to 17 with a BMI at or above the 85th percentile, will either receive these classes alongside their usual diabetes care or continue with routine care alone. The study measures changes in HbA1c, weight, BMI, and nutrition knowledge to see if the cooking program makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Virtual cooking classes with a diabetes educator, nutritionist, and professional chef, added to routine diabetes care
- What this could lead to
- If effective, this program could offer a practical, budget-friendly way to help teens with type 1 diabetes improve blood sugar control and learn healthier eating habits.
- What could go wrong
- This is a small, early-stage study, so results may not apply broadly. The intervention is educational, and benefits may vary; there is also a risk that participation may not lead to significant improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
46 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * be diagnosed with T1D for at least a year * be 12 to 17 years of age at time of study enrollment * have a BMI ≥ 85th percentile * be able to communicate via a virtual platform if needed * intend to maintain status as a patient at the Children's Hospital of Pittsburgh Diabetes Center throughout the study duration. Exclusion Criteria: \- diagnosis of other types of diabetes (such as type 2 diabetes, MODY, cystic fibrosis related diabetes or diabetes secondary to medications).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness tame diabetes distress and blood sugar?
- Can an mRNA vaccine shield the most vulnerable from RSV?
- Can a simple patch stop diabetes device skin woes?
- Could a smart pen take the guesswork out of insulin dosing?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?
- Can a common diabetes pill make insulin therapy safer and more effective for type 1 diabetes?